Bekker said it requires a good health need to ensure that for each common company, it will be valuable in the meantime, Bekker said. We all hope that governments (across Africa Sahara) are writing a common product on their budget for the future, but in fact, we have relied on the sponsorship of the talented house. aid. Even my country, South Africa, has good GDP and 80 % of its HIV reaction, has purchased Retrovirals anti -Retrovirals for 6 million individuals each year. I will imagine them will take a few years to be able to mobilize money for Lenacapavir.
With Pepfar seems to be focusing primarily on the treatment of existing patients, with preventive costs, clinicians like Nomathemba Chandiwana, a doctor-scientist at Desmond Tutu Health Fund in Men in Men Africa, concerned that the infection rate will begin to increase rather than instead of autumn, something will have a significant impact on public health across the African continent and more.
Speaking at the NCD Union last week in Kigali, Chandiwana explained that the consequences of new infections were not only related to HIV itself. Research increasingly shows that people with HIV -infected HIV long -term, even those who are controlled with antacidic drugs, are at risk of developing metabolic conditions such as hypertension, obesity and disease. Type 2 diabetes, a burden of disease increasing Africa Sahara. Chandiwana said HIV has broken your metabolism, as well as many anti -virus drugs, Chandiwana said. We see similar chronic diseases in HIV -infected people like we do in the population in general, but at earlier age and in the form of acceleration.
Because of this, it is also necessary to have a new generation of HIV treatment and a concept of discovery is to use Lenacapavir as a foundation of future combined therapies for those who have had viruses. As well as being able to reduce some side effects, it is expected that this can lead to non -HIV -infected treatment protocols daily.
Different ideas have been given, Bekker said. You can combine Cabotegravir every two months with six -month lenacapavir injection (as a form of virus inhibitors), so you only reach six times a year for treatment, and will be injected? There is an antiviral tablet weekly in buildings, and can you combine it with six months of injection? This can be very free for everyone, because they tell us how stigma needs to take daily.
However, many of these studies are now suspected, as Bekker says they are expected to be funded by US resources. This is not just Pepfar; We are also worried about the limitations placed in other types of research sponsors, such as the National Health Institute, she said. This will become more difficult to innovate and move forward.
According to Ngue, there is still hope that other donors can emerge, those who can support the global fund in the purchase of Lenacapavir, while Bekker says she is exploring new options to sponsoring for funding for funding. The prevention and research of HIV through European agencies and can fund sources from sources in Scandinavia, Japan and Australia. At the same time, she believed that the events of the past month illustrated that African countries needed to become more likely to sponsor preventive efforts.
In some way, Africa needs to step up and contribute to the war, she said. I think it is a big question. How much can we contribute to this continent through countries that do not necessarily include a large amount of research and development but in the future it is necessary to have.
At the same time, she was afraid that without similar resources from the US, the only chance provided by Lenacapavir could be lost.
It is unbelievable that this happened like we had a breakthrough, she said. I think this will make us back for many years and finally cost more in public health spending. Because in the end, if we can control the disease faster, it will save the planet more money for a long time and save lives.